Mainz Biomed (MYNZ) Stock Price
Mainz Biomed Price
Over the last 6 years Mainz Biomed grew revenue by 11.4% annually, reaching 537,080.00 USD. For Mainz Biomed, the net margin of -3,018.3% is down versus -2,024.8% a few years ago. The consensus 12-month price target for Mainz Biomed is 2.04 USD, about 100.0% above where the stock trades today. Of 8 analysts, 6 rate the stock a buy — an overall Buy consensus.
Mainz Biomed stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Mainz Biomed business model & stock analysis
Frequently asked questions about Mainz Biomed
Analysts currently set an average price target of 2.04 USD for the Mainz Biomed stock (median: 2.04 USD), implying +100.0 % versus the latest price. The consensus is based on 8 analyst ratings.
7 analysts currently rate the Mainz Biomed stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Mainz Biomed to generate revenue of 918,000.00 USD and earnings per share of -2.28 USD.
Converted at the current exchange rate, the Mainz Biomed share trades at 0.91 EUR (1.02 USD).
The Mainz Biomed share (MYNZ) is listed on 6 stock exchanges, including: NASDAQ (MYNZ), XETRA (4TO.DE), Frankfurt (4TO.F), München (4TO.MU), Düsseldorf (4TO.DU), Hamburg (4TO.HM).
The expected revenue of Mainz Biomed is 918,000.00 USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Mainz Biomed is -13.68 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Mainz Biomed is currently -0.45. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Mainz Biomed stock.
The price-to-sales ratio (P/S) of Mainz Biomed is currently 6.66. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Mainz Biomed stock.
The Eulerpool Quality Score for Mainz Biomed is 2/10.
The ISIN of Mainz Biomed is NL0015000LC2. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Mainz Biomed is A3C6XX. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Mainz Biomed is MYNZ. The ticker symbol is used to trade Mainz Biomed shares on the stock exchange.
Mainz Biomed stock
Mainz Biomed Peer Group
Mainz Biomed Ticker
Mainz Biomed FIGI
All fundamentals and in-depth analysis of Mainz Biomed
Our stock analysis for Mainz Biomed stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mainz Biomed. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.